Options, limits and ethics of pharmacological neuroenhancement;Möglichkeiten und Grenzen des pharmakologischen Neuroenhancements

Nervenarzt

Volumn 81, Issue 1, 2010, Pages 66-74

  Normann, C ^a   Boldt, J ^b   Maio, G ^b   Berger, M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cognition; Ethics; Learning; Neuroenhancers; Plasticity

Indexed keywords

ALERTNESS; ATTENTION; COGNITION; ETHICS; HUMAN; LEARNING; MEMORY; MENTAL CAPACITY; NERVE CELL PLASTICITY; PSYCHOPHARMACOLOGY; REVIEW; SOCIAL INTERACTION;

AROUSAL; BIOMEDICAL ENHANCEMENT; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; GERMANY; HUMANS;

EID: 77249124300     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-009-2858-2     Document Type: Review

References (64)

1. Amado-Boccara I, Gougoulis N, Poirier Littre MF et al (1995) Effects of antidepressants on cognitive functions: a review. Neurosci Biobehav Rev 19:479-493
2. Arai AC, Kessler M (2007) Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior. Curr Drug Targets 8:583-602
3. Babcock Q, Byrne T (2000) Student perceptions of methylphenidate abuse at a public liberal arts college. J Am Coll Health 49:143-145
4. Ballon JS, Feifel D (2006) A systematic review of modafinil: Potential clinical uses and mechanisms of action. J Clin Psychiatry 67:554-566
5. Barad M, Bourtchouladze R, Winder DG et al (1998) Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory. Proc Natl Acad Sci U S A 95:15020-15025
6. Baranski JV, Pigeau R, Dinich P et al (2004) Effects of modafinil on cognitive and meta-cognitive performance. Hum Psychopharmacol 19:323-332
7. Birks J, Grimley Evans J (2007) Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev:CD003120
8. Bliss TV, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31-39
9. Bliss TV, Lomo T (1973) Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 232:331-356
10. Boldt J, Maio G (2009) Neuroenhancement - Vom technizistischen Mißverständnis geistiger Leistungsfähigkeit. In: Müller O, Clausen J (Hrsg) Das technisierte Gehirn. Ändern die aktuellen Neurotechnologien das menschliche Selbstvertändnis? Mentis, Paderborn
11. Buguet A, Montmayeur A, Pigeau R et al (1995) Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. II. Effects on two nights of recovery sleep. J Sleep Res 4:229-241 (Pubitemid 26010120)
12. Chamberlain SR, Muller U, Blackwell AD et al (2006) Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 311:861-863
13. Chatterjee A (2004) Cosmetic neurology: the controversy over enhancing movement, mentation, and mood. Neurology 63:968-974
14. Dees RH (2004) Slippery slopes, wonder drugs, and cosmetic neurology: the neuroethics of enhancement. Neurology 63:951-952
15. Dommett EJ, Henderson EL, Westwell MS et al (2008) Methylphenidate amplifies long-term plasticity in the hippocampus via noradrenergic mechanisms. Learn Mem 15:580-586
16. Dudek SM, Bear MF (1992) Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-D-aspartate receptor blockade. Proc Natl Acad Sci U S A 89:4363-4367
17. Elliott C (1998) The tyranny of happiness: ethics and cosmetic psychopharmacology. In: Parens E (ed) Enhancing human traits. Ethical and social implications. Georgetown Univ Press, Washington D.C., p 177-188
18. Elliott R, Sahakian BJ, Matthews K et al (1997) Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology 131:196-206
19. Farah MJ, Illes J, Cook-Deegan R et al (2004) Neurocognitive enhancement: what can we do and what should we do? Nat Rev Neurosci 5:421-425
20. Ferre S (2008) An update on the mechanisms of the psychostimulant effects of caffeine. J Neurochem 105:1067-1079
21. Gage FH (2000) Mammalian neural stem cells. Science 287:1433-1438
22. Gasser P (1996) Die psycholytische Psychotherapie in der Schweiz von 1988-1993. Schweiz Archiv Neurol Psychiatr 147:56-65
23. Gill M, Haerich P, Westcott K et al (2006) Cognitive performance following modafinil versus placebo in sleep-deprived emergency physicians: a double-blind randomized crossover study. Acad Emerg Med 13:158-165
24. Greely H, Sahakian B, Harris J et al (2008) Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 456:702-705
25. Harmer CJ, Shelley NC, Cowen PJ et al (2004) Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry 161:1256-1263
26. Hebb DO (1949) The organization of behaviour. a neuropsychological theory. Wiley, New York
27. Hermle L, Spitzer M, Borchardt D et al (1993) Psychological effects of MDE in normal subjects. Are entactogens a new class of psychoactive agents? Neuropsychopharmacology 8:171-176
28. Hofmann SG, Pollack MH, Otto MW (2006) Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine. CNS Drug Rev 12:208-217
29. Iwamoto K, Takahashi M, Nakamura Y et al (2008) The effects of acute treatment with paroxetine, amitriptyline, and placebo on driving performance and cognitive function in healthy Japanese subjects: a double-blind crossover trial. Hum Psychopharmacol 23:399-407
30. Maio G (2007) Die moderne Dienstleistungsmedizin auf ethischem Prüfstand. Schweiz Ärztez 88
31. Maio G (2007) Medizin auf Wunsch? Eine ethische Kritik der präferenzorientierten Medizin, dargestellt am Beispiel der Ästhetischen Chirurgie. Dtsch Med Wochenschr 132:2278-2281
32. Minzenberg MJ, Carter CS (2008) Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology 33:1477-1502
33. Muller U, Steffenhagen N, Regenthal R et al (2004) Effects of modafinil on working memory processes in humans. Psychopharmacology 177:161-169
34. Normann C, Berger M (2008) Neuroenhancement: status quo and perspectives. Eur Arch Psychiatry Clin Neurosci 258 [Suppl 5]:110-114
35. Normann C, Peckys D, Schulze CH et al (2000) Associative long-term depression in the hippocampus is dependent on postsynaptic N-type Ca2+ channels. J Neurosci 20:8290-8297
36. Northoff G, Witzel J, Bogerts B (2006) Was ist .,Neuroethik" - eine Disziplin der Zukunft? Nervenarzt 77:5-11
37. Parens E (2005) Authenticity and ambivalence: toward understanding the enhancement debate. Hastings Cent Rep 35:34-41
38. Pigeau R, Naitoh P, Buguet A et al (1995) Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature. J Sleep Res 4:212-228 (Pubitemid 26010119)
39. Randall Dc, Fleck Nl, Shneerson Jm et al (2004) The cognitive-enhancing properties of modafinil are limited in non-sleep-deprived middle-aged volunteers. Pharmacol Biochem Behav 77:547-555
40. Randall Dc, Shneerson Jm, File Se (2005) Cognitive effects of modafinil in student volunteers may depend on IQ. Pharmacol Biochem Behav 82:133-139
41. Randall Dc, Shneerson Jm, Plaha Kk et al (2003) Modafinil affects mood, but not cognitive function, in healthy young volunteers. Hum Psychopharmacol 18:163-173
42. Randall DC, Viswanath A, Bharania P et al (2005) Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived? J Clin Psychopharmacol 25:175-179
43. Ressler KJ, Rothbaum BO, Tannenbaum L et al (2004) Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 61:1136-1144
44. Rose GM, Hopper A, De Vivo M et al (2005) Phosphodiesterase inhibitors for cognitive enhancement. Curr Pharm Des 11:3329-3334
45. Rutten K, Lieben C, Smits L et al (2007) The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat. Psychopharmacology 192:275-282
46. Sahakian B, Morein-Zamir S (2007) Professors little helper. Nature 450:1157-1159
47. Schäfer D, Groß G (2008) Neuroenhancement. Eingriff in die personale Identität. Dtsch Ärztebl 105:3
48. Schleim S, Walter H (2007) Cognitive Enhancement. Fakten und Mythen. Nervenheilkunde 26:5
49. Schöne-Seifert B (2006) Pillen-Glück statt Psycho-Arbeit. Was wäre dagegen einzuwenden? In: Ach JS (ed) No body is perfect. Baumaßnahmen am menschlichen Körper. Transcript, Bielefeld
50. Siepmann M, Grossmann J, Muck-Weymann M et al (2003) Effects of sertraline on autonomic and cognitive functions in healthy volunteers. Psychopharmacology 168:293-298
51. Siepmann M, Werner K, Schindler C et al (2005) The effects of bupropion on cognitive functions in healthy subjects. Psychopharmacology 182:597-598
52. Solomon PR, Adams F, Silver A et al (2002) Ginkgo for memory enhancement: a randomized controlled trial. JAMA 288:835-840
53. Teter CJ, Mccabe SE, Lagrange K et al (2006) Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 26:1501-1510
54. Toni N, Buchs PA, Nikonenko I et al (1999) LTP promotes formation of multiple spine synapses between a single axon terminal and a dendrite. Nature 402:421-425
55. Tully T, Bourtchouladze R, Scott R et al (2003) Targeting the CREB pathway for memory enhancers. Nat Rev Drug Discov 2:267-277
56. Turner DC, Robbins TW, Clark L et al (2003) Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology 165:260-269
57. Turner DC, Robbins TW, Clark L et al (2003) Relative lack of cognitive effects of methylphenidate in elderly male volunteers. Psychopharmacology 168:455-464
58. Vervliet B (2008) Learning and memory in conditioned fear extinction: effects of D-cycloserine. Acta Psychol 127:601-613
59. Volkow nd, Fowler JS, Wang GJ et al (2008) Methylphenidate decreased the amount of glucose needed by the brain to perform a cognitive task. PloS ONE 3
60. Vollenweider FX, Gamma A, Liechti M et al (1998) Psychological and cardiovascular effects and short-term sequelae of MDMA (.,ecstasy") in MDMA-naive healthy volunteers. Neuropsychopharmacology 19:241-251
61. Wesensten NJ (2006) Effects of modafinil on cognitive performance and alertness during sleep deprivation. Curr Pharm Des 12:2457-2471
62. Whitlock JR, Heynen AJ, Shuler MG et al (2006) Learning induces long-term potentiation in the hippocampus. Science 313:1093-1097
63. Wolpe PR (2002) Treatment, enhancement, and the ethics of neurotherapeutics. Brain Cogn 50:387-395
64. Yesavage JA, Mumenthaler MS, Taylor JL et al (2002) Donepezil and flight simulator performance: effects on retention of complex skills. Neurology 59:123-125